The epidemiology of cancer in people with HIV

Andrew E. Grulich, Diego Serraino, Denise Whitby

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Three types of cancer, namely Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL), and cervical cancer, are formally designated as AIDS-defining cancers. KS occurs many thousandfold more commonly in people with HIV than in the general population and is causally associated with infection with human herpesvirus-8. Incidence of KS has greatly decreased in recent years in those populations of people with HIV who have access to highly active antiretroviral therapy (HAART). NHL occurs 50-to 100-fold more commonly in people with HIV than in the general population and in a proportion of cases is related to Epstein-Barr virus (EBV) infection. Use of HAART has also resulted in substantial declines in incidence of NHL. Cervical cancer occurs up to 20 times more commonly in people with HIV than in the general population, and rates have been little affected by HAART use in recent years. In addition to the AIDS-defining cancers, it has recently become clear that a wider range of mostly viral-associated cancers occur at increased rates in people with HIV. These include Hodgkin's disease, the range of anogenital and oropharyngeal human papillomavirus associated cancers, liver cancer, and conjunctival cancers. Whether or not other cancers - including lung cancer and non-melanoma skin cancer - are associated with HIV infection is the subject of ongoing study.

Original languageEnglish
Title of host publicationMolecular Basis for Therapy of AIDS-Defining Cancers
PublisherSpringer New York
Pages1-16
Number of pages16
ISBN (Print)9781441915122
DOIs
Publication statusPublished - 2010

Fingerprint

Epidemiology
Viruses
Liver
Skin
HIV
Kaposi's Sarcoma
Highly Active Antiretroviral Therapy
Non-Hodgkin's Lymphoma
Neoplasms
Liver Neoplasms
Uterine Cervical Neoplasms
Population
Lung Neoplasms
Acquired Immunodeficiency Syndrome
Human Herpesvirus 8
Epstein-Barr Virus Infections
Incidence
Skin Neoplasms
Hodgkin Disease
HIV Infections

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Grulich, A. E., Serraino, D., & Whitby, D. (2010). The epidemiology of cancer in people with HIV. In Molecular Basis for Therapy of AIDS-Defining Cancers (pp. 1-16). Springer New York. https://doi.org/10.1007/978-1-4419-1513-9_1

The epidemiology of cancer in people with HIV. / Grulich, Andrew E.; Serraino, Diego; Whitby, Denise.

Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, 2010. p. 1-16.

Research output: Chapter in Book/Report/Conference proceedingChapter

Grulich, AE, Serraino, D & Whitby, D 2010, The epidemiology of cancer in people with HIV. in Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, pp. 1-16. https://doi.org/10.1007/978-1-4419-1513-9_1
Grulich AE, Serraino D, Whitby D. The epidemiology of cancer in people with HIV. In Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York. 2010. p. 1-16 https://doi.org/10.1007/978-1-4419-1513-9_1
Grulich, Andrew E. ; Serraino, Diego ; Whitby, Denise. / The epidemiology of cancer in people with HIV. Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, 2010. pp. 1-16
@inbook{b9b269b0a07248e0a489f305799c102c,
title = "The epidemiology of cancer in people with HIV",
abstract = "Three types of cancer, namely Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL), and cervical cancer, are formally designated as AIDS-defining cancers. KS occurs many thousandfold more commonly in people with HIV than in the general population and is causally associated with infection with human herpesvirus-8. Incidence of KS has greatly decreased in recent years in those populations of people with HIV who have access to highly active antiretroviral therapy (HAART). NHL occurs 50-to 100-fold more commonly in people with HIV than in the general population and in a proportion of cases is related to Epstein-Barr virus (EBV) infection. Use of HAART has also resulted in substantial declines in incidence of NHL. Cervical cancer occurs up to 20 times more commonly in people with HIV than in the general population, and rates have been little affected by HAART use in recent years. In addition to the AIDS-defining cancers, it has recently become clear that a wider range of mostly viral-associated cancers occur at increased rates in people with HIV. These include Hodgkin's disease, the range of anogenital and oropharyngeal human papillomavirus associated cancers, liver cancer, and conjunctival cancers. Whether or not other cancers - including lung cancer and non-melanoma skin cancer - are associated with HIV infection is the subject of ongoing study.",
author = "Grulich, {Andrew E.} and Diego Serraino and Denise Whitby",
year = "2010",
doi = "10.1007/978-1-4419-1513-9_1",
language = "English",
isbn = "9781441915122",
pages = "1--16",
booktitle = "Molecular Basis for Therapy of AIDS-Defining Cancers",
publisher = "Springer New York",

}

TY - CHAP

T1 - The epidemiology of cancer in people with HIV

AU - Grulich, Andrew E.

AU - Serraino, Diego

AU - Whitby, Denise

PY - 2010

Y1 - 2010

N2 - Three types of cancer, namely Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL), and cervical cancer, are formally designated as AIDS-defining cancers. KS occurs many thousandfold more commonly in people with HIV than in the general population and is causally associated with infection with human herpesvirus-8. Incidence of KS has greatly decreased in recent years in those populations of people with HIV who have access to highly active antiretroviral therapy (HAART). NHL occurs 50-to 100-fold more commonly in people with HIV than in the general population and in a proportion of cases is related to Epstein-Barr virus (EBV) infection. Use of HAART has also resulted in substantial declines in incidence of NHL. Cervical cancer occurs up to 20 times more commonly in people with HIV than in the general population, and rates have been little affected by HAART use in recent years. In addition to the AIDS-defining cancers, it has recently become clear that a wider range of mostly viral-associated cancers occur at increased rates in people with HIV. These include Hodgkin's disease, the range of anogenital and oropharyngeal human papillomavirus associated cancers, liver cancer, and conjunctival cancers. Whether or not other cancers - including lung cancer and non-melanoma skin cancer - are associated with HIV infection is the subject of ongoing study.

AB - Three types of cancer, namely Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL), and cervical cancer, are formally designated as AIDS-defining cancers. KS occurs many thousandfold more commonly in people with HIV than in the general population and is causally associated with infection with human herpesvirus-8. Incidence of KS has greatly decreased in recent years in those populations of people with HIV who have access to highly active antiretroviral therapy (HAART). NHL occurs 50-to 100-fold more commonly in people with HIV than in the general population and in a proportion of cases is related to Epstein-Barr virus (EBV) infection. Use of HAART has also resulted in substantial declines in incidence of NHL. Cervical cancer occurs up to 20 times more commonly in people with HIV than in the general population, and rates have been little affected by HAART use in recent years. In addition to the AIDS-defining cancers, it has recently become clear that a wider range of mostly viral-associated cancers occur at increased rates in people with HIV. These include Hodgkin's disease, the range of anogenital and oropharyngeal human papillomavirus associated cancers, liver cancer, and conjunctival cancers. Whether or not other cancers - including lung cancer and non-melanoma skin cancer - are associated with HIV infection is the subject of ongoing study.

UR - http://www.scopus.com/inward/record.url?scp=84900229360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900229360&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1513-9_1

DO - 10.1007/978-1-4419-1513-9_1

M3 - Chapter

SN - 9781441915122

SP - 1

EP - 16

BT - Molecular Basis for Therapy of AIDS-Defining Cancers

PB - Springer New York

ER -